Earlier versions of a spending cuts package passed through Congress targeted PEPFAR. But the White House, concerned about ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Adults who switched from daily ART to long-acting cabotegravir-rilpivirine showed high levels of virologic suppression, high ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...

This groundbreaking HIV initiative designed to meet Black and LGBTQ+ communities where they are — spiritually, culturally, ...

In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...

HIV care and its related outcomes in South Carolina were defined by racial disparities, specifically in retention in care, ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...